Overview
Hi, what are you loking for?ByPublishedThe Global Negative pressure Wound Therapy Systems (NPWT) Market was valued at USD 3.35 billion in 2021, growing at a CAGR of 5.09% during the forecast period from 2022 to 2027, in order to reach USD 4.50 billion by 2027. Factors such as the rising incidence of chronic wounds associated with various chronic disorders such as diabetes, ulcers, obesity, and also with the rising incidence of active wounds comprising burns, surgical wounds, among others are driving the overal market growth.
Key Information
Further, an increase in the aging population, increasing awarenes of proper wound care management, rising funding for wound care research, and technological advancements in wound care product oferings are also driving the market.Some of the key market players operating in the Negative pressure Wound Therapy Systems market include 3M (NYSE: M), Cardinal Health (NYSE: CAH), ConvaTec Group PLC (LON: CTEC), DeRoyal Industries, Inc., Devon Group, Medela AG, Smith & Nephew PLC (LON: SN), Mölnlycke Health Care AB, Direct Healthcare Group, Acel-Heal Technologies Ltd., B.
Summary
Braun Melsungen AG, Lohman & Rauscher, Cenefom Corp., PAUL HARTMAN Asia-Pacific Ltd., Carilex Medical, Chongqing Sunshine Medical Industry and Trading Co., Ltd., Foryou Medical Electronics Co., Ltd., OncoVista Inovative Therapies, Genadyne, Cork Medical, LC, among others.DelveInsight’s ̴Negative pressure Wound Therapy Systems Market Insight & Forecast̵ report wil ofer an in-depth understanding of the Negative pressure Wound Therapy Systems market, further benefiting the competitors or stakeholders operating in the Negative pressure Wound Therapy Systems arena.Negative pressure Wound Therapy Systems OverviewNegative pressure wound therapy (NPWT), also known as vacum-asisted wound closure is a wound dresing system that provides continuous or intermitent subatmospheric pressure to the system which further provides positive pressure continues to improve outcomes for patients. Healthcare professionals emphasize the importance of early intervention and comprehensive management strategies in reducing complications and improving quality of life.